Drugs / PF-02921367
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07206225 Background | Nov 2025 → Jan 2030 expected | non-invasive bladder urothelial carcinoma | Pfizer | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PF-02921367 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07206225 ↗ |